Search - tctmd.com

Displaying 241 - 260 of 465

Sort: Relevancy | Date

News Daily News

Una Calculadora Estima el Riesgo de IM Espontáneo en Pacientes Víctimas de SCASEST Tratados Médicamente

Todd Neale

March 16, 2016

News Daily News

Suboptimal Care for Women With CAD Linked to Higher Long-Term Mortality

Caitlin E. Cox

February 28, 2016

News Daily News

Los Cuidados Subóptimos de Mujeres con EAC se asocian a una Mayor Mortalidad a Largo Plazo

Caitlin E. Cox

February 28, 2016

News Daily News

Ticagrelor Loading Dose Provides Faster Platelet Inhibition Than Clopidogrel in Ad Hoc PCI

L.A. McKeown

February 09, 2016

News Daily News

Good News from ACTION GWTG Registry: Most Hospitals Doing Quite Well at Acute MI Care

Caitlin E. Cox

January 31, 2016

News Daily News

Buenas Noticias del Registro ACTION GWTG: La Mayoría de Hospitales tiene un Buen Rendimiento en el Manejo de IAM

Caitlin E. Cox

January 31, 2016

News Daily News

Interhospital Transfer for Acute MI Associated With Disruptions in Aftercare, More Readmissions

L.A. McKeown

January 27, 2016

News Daily News

La Derivación Interhospitalaria de los IAM provoca Interrupciones en los Cuidados Posteriores y Más Rehospitalizaciones

L.A. McKeown

January 27, 2016

News Daily News

Triple Therapy, Especially With Prasugrel, Increases Bleeding Risk in Acute MI

Yael L. Maxwell

December 22, 2015

News Daily News

El Tratamiento Triple, sobre todo con Prasugrel, Aumenta el Riesgo Hemorrágico de los IAM

Yael L. Maxwell

December 22, 2015

News Daily News

Early Data Show Promise for Reversible, Fast-Acting, Antiplatelet Drug PZ-128

Caitlin E. Cox

December 20, 2015

News Daily News

Prometedores Primeros Datos para el Fármaco Antiplaquetario Reversible de Acción Rápida PZ-128

Caitlin E. Cox

December 20, 2015

News Daily News

Case Study Highlights Risks for A-fib Patients Undergoing PCI in Absence of Evidence-Based Guidelines

Yael L. Maxwell

December 14, 2015

News Conference News AHA 2015

Most Drug Discontinuations in PEGASUS-TIMI 54 Related to Dyspnea, Bleeding

Todd Neale

November 10, 2015

News Conference News TCT 2015

Discussion Highlights Merits, Limitations of Small Trials

Yael L. Maxwell

October 13, 2015

News Daily News

RECLOSE-3: Shifting Clopidogrel Nonresponders to Prasugrel Lowers Mortality After PCI

Yael L. Maxwell

September 18, 2015

News Daily News

RECLOSE-3: Cambiar a Clopidogrel a No Respondedores al Prasugrel Reduce la Mortalidad Post-PCI

Yael L. Maxwell

September 18, 2015

News Conference News ESC 2015

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

September 09, 2015

News Industry News

Bristol-Myers Squibb and Pfizer Enroll First Patient in Phase 4 AUGUSTUS Trial to Evaluate Safety of Eliquis (apixaban) in Nonvalvular Atrial Fibrillation Patients with a Recent ACS or Undrgoing PCI

September 09, 2015

News Industry News

New Haven Pharmaceuticals Receives FDA Approval for DURLAZA™ (aspirin) Extended Release Capsules for Secondary Prevention of Stroke and Acute Cardiac Events

September 08, 2015

Advertisement

Una Calculadora Estima el Riesgo de IM Espontáneo en Pacientes Víctimas de SCASEST Tratados Médicamente

Suboptimal Care for Women With CAD Linked to Higher Long-Term Mortality

Los Cuidados Subóptimos de Mujeres con EAC se asocian a una Mayor Mortalidad a Largo Plazo

Ticagrelor Loading Dose Provides Faster Platelet Inhibition Than Clopidogrel in Ad Hoc PCI

Good News from ACTION GWTG Registry: Most Hospitals Doing Quite Well at Acute MI Care

Buenas Noticias del Registro ACTION GWTG: La Mayoría de Hospitales tiene un Buen Rendimiento en el Manejo de IAM

Interhospital Transfer for Acute MI Associated With Disruptions in Aftercare, More Readmissions

La Derivación Interhospitalaria de los IAM provoca Interrupciones en los Cuidados Posteriores y Más Rehospitalizaciones

Triple Therapy, Especially With Prasugrel, Increases Bleeding Risk in Acute MI

El Tratamiento Triple, sobre todo con Prasugrel, Aumenta el Riesgo Hemorrágico de los IAM

Early Data Show Promise for Reversible, Fast-Acting, Antiplatelet Drug PZ-128

Prometedores Primeros Datos para el Fármaco Antiplaquetario Reversible de Acción Rápida PZ-128

Case Study Highlights Risks for A-fib Patients Undergoing PCI in Absence of Evidence-Based Guidelines

Most Drug Discontinuations in PEGASUS-TIMI 54 Related to Dyspnea, Bleeding

Discussion Highlights Merits, Limitations of Small Trials

RECLOSE-3: Shifting Clopidogrel Nonresponders to Prasugrel Lowers Mortality After PCI

RECLOSE-3: Cambiar a Clopidogrel a No Respondedores al Prasugrel Reduce la Mortalidad Post-PCI

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

Bristol-Myers Squibb and Pfizer Enroll First Patient in Phase 4 AUGUSTUS Trial to Evaluate Safety of Eliquis (apixaban) in Nonvalvular Atrial Fibrillation Patients with a Recent ACS or Undrgoing PCI

New Haven Pharmaceuticals Receives FDA Approval for DURLAZA™ (aspirin) Extended Release Capsules for Secondary Prevention of Stroke and Acute Cardiac Events

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content